GABRE
Basic information
Region (hg38): X:151953124-151974680
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GABRE gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 32 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 6 | 5 |
Variants in GABRE
This is a list of pathogenic ClinVar variants found in the GABRE region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-151954708-T-C | not specified | Uncertain significance (Mar 26, 2024) | ||
X-151954786-C-A | not specified | Uncertain significance (Mar 07, 2023) | ||
X-151954786-C-T | not specified | Uncertain significance (May 21, 2024) | ||
X-151954807-C-T | GABRE-related disorder | Likely benign (Nov 26, 2021) | ||
X-151954868-G-C | Benign (Apr 03, 2018) | |||
X-151954875-C-G | not specified | Uncertain significance (Aug 19, 2023) | ||
X-151954910-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
X-151954917-C-G | Benign (May 09, 2018) | |||
X-151955029-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
X-151955033-A-G | Uncertain significance (Mar 03, 2021) | |||
X-151955045-G-A | GABRE-related epilepsy | Uncertain significance (Jan 07, 2022) | ||
X-151955045-G-C | not specified | Uncertain significance (Jan 30, 2024) | ||
X-151955050-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
X-151955051-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
X-151955056-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
X-151955060-C-T | Likely benign (-) | |||
X-151955069-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
X-151955373-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
X-151955379-T-C | not specified | Uncertain significance (Feb 23, 2023) | ||
X-151955445-C-T | not specified | Uncertain significance (Nov 23, 2022) | ||
X-151955472-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
X-151955509-C-T | Likely benign (Mar 01, 2020) | |||
X-151955522-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
X-151955530-G-T | Uncertain significance (-) | |||
X-151955538-A-G | Benign (Sep 29, 2017) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GABRE | protein_coding | protein_coding | ENST00000370328 | 9 | 21557 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000184 | 0.903 | 125732 | 7 | 7 | 125746 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0720 | 211 | 208 | 1.01 | 0.0000172 | 3322 |
Missense in Polyphen | 65 | 87.903 | 0.73945 | 1349 | ||
Synonymous | 0.605 | 70 | 76.7 | 0.912 | 0.00000620 | 982 |
Loss of Function | 1.51 | 8 | 14.1 | 0.567 | 9.55e-7 | 254 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000228 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000144 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000112 | 0.0000791 |
Middle Eastern | 0.000144 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.;
- Pathway
- Retrograde endocannabinoid signaling - Homo sapiens (human);GABAergic synapse - Homo sapiens (human);Nicotine addiction - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Morphine addiction - Homo sapiens (human);GABA receptor Signaling
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.188
- rvis_EVS
- 1.82
- rvis_percentile_EVS
- 97.01
Haploinsufficiency Scores
- pHI
- 0.416
- hipred
- N
- hipred_score
- 0.215
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.254
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gabre
- Phenotype
Gene ontology
- Biological process
- signal transduction;gamma-aminobutyric acid signaling pathway;chemical synaptic transmission;ion transmembrane transport;regulation of membrane potential;nervous system process;synaptic transmission, GABAergic;regulation of postsynaptic membrane potential;chloride transmembrane transport;negative regulation of chloride transport
- Cellular component
- integral component of plasma membrane;cell junction;dendrite membrane;chloride channel complex;neuron projection;synapse;postsynaptic membrane;postsynapse;GABA-A receptor complex
- Molecular function
- GABA-A receptor activity;extracellular ligand-gated ion channel activity;inhibitory extracellular ligand-gated ion channel activity;chloride channel activity;benzodiazepine receptor activity;GABA-gated chloride ion channel activity;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential